维普期刊资源整合服务平台（V6.5）

431篇 您的检索式：作者名="Haneda M"

选中清除导出查看参考文献查看引证文献引用追踪共22页首页上一页第1页下一页末页 /22 跳转

	题名	作者	年代	出处	被引量
1	Enhancement of glomerular hemeoxygenase-1 expression in diabetic rats显示文摘	Hayashi K Haneda M Koya D	2001	Diabetes Res Clin Pract2001，52，2：	1
2	Cellular mechanisms in the development and progression of diabetic nephropathy : activa- tion of the DAG-PKC-ERK pathway 显示文摘	Haneda M Koya D Kikkawa R	2001	Am J Kidney Dis2001，38，41：	1
3	Predictive effects of urinary liver-type fatty acid-binding protein for deterio- rating renal function and incidence of cardiovascular dis- ease in type 2 diabetic patients without advanced nephropathy显示文摘	Araki S Haneda M Koya D	2013	Diabetes Care2013，36，5：	1
4	Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rat显示文摘	Isshiki K Haneda M koya D	2000	Diabetes2000，49，6：	1
5	Progression of diabetic nephropathy显示文摘	Kikkawa R Koya D Haneda M	2003	J Am Kidney Dis2003，41，：	1
6	Overview of glucose signaling in mesangial cells in diabetic nephropathy显示文摘	Haneda M Koya D Isono M	2003	J Am Soc Nephrol2003，，：	1
7	Prooxidant activity of curcumin: copper-dependent formation of 8-hy- droxy-20-deoxyguanosine in DNA and induction of apoptotic cell death显示文摘	Yoshino M Haneda M Naruse M	2004	Toxicol In Vitro2004，18，6：	1
8	Promotional effect of SO2 on the activity of Ir/SiO2 or NOx reduction with CO under oxygenrich conditions显示文摘	Haneda M Pusparatu Kintaichi Y	2005	Journal of catalysis2005，229，1：	1
9	Cellular mechanisms in the development and progression of diabetic nephropathy:activation of the DAG-PKC-ERK pathway显示文摘	HANEDA M KOYA D KIKKAWA R	2001	Am J Kidney Dis2001，38，4：	1
10	显示文摘	Haneda M Araki S Togawa M	1997	Diabetes1997，46，：	1
11	Revised criteria for the early diagnosis of diabetic nephropathy显示文摘	Inomat S Haneda M Moriya T	2005	Nippon Jinzo Gakkai Shi2005，47，7：	1
12	Microalbuminuria reduction with telmisartan in mormotensive and hypertensive Japanese patients with type 2 diabetes:a post-hoc analysis of the incipient to overt:an- giotensin Ⅱ blocker, telmisartan, investigation on type 2 diabetic ne- phropathy (INNOVATION) study显示文摘	Makino H Haneda M Babazono T	2008	Hypertens Res2008，31，4：	1
13	显示文摘	Skita M Haneda H Yanagitani T	1990	J Appl Phys1990，67，1：	1
14	Overview of glucose signaling in mesangial cells in diabetic nephropathy显示文摘	Haneda M Koya D Isono M	2003	J Am Soc Nephrol2003，14，：	1
15	Role Of mitogen - acfi - vated protein Kinases as downstream effectors of transforming growth factor beta in mesangial cells 显示文摘	ISOI K HANEDA M ISHINA T	2000	Kidney Int2000，58，177：	1
16	显示文摘	Haneda M Watanabe T Kamiuchi N	2013	Appl Catal B2013，1421，43：	1
17	Effect of addition on Y2O3 in ZrO2 support on n-butane Pt catalyzed oxidation显示文摘	BONNE M HANEDA M DUPREZ D	2012	Catalysis Communications2012，19，：	1
18	Abnormal angiogenesis in diabetic nephropathy显示文摘	Nakagawa T Kosugi T Haneda M	2009	Diabetes2009，58，7：	1
19	Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin sensitizing action in diabetic rats 显示文摘	ISSHIKI K HANEDA M KOYA D	2000	Diabetes2000，49，6：	1
20	In vivo mapping ofsub- stance P receptors in brains of laboratory animals by high-res- olution imaging systerns显示文摘	Haneda E Higuchi M Maeda J	2007	Synapse2007，61，4：	1

返回顶部每页显示：

共22页首页上一页第1页下一页末页 /22 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示